We leveraged data from the clinical trials MELANFα (NCT03348891) and TICIMEL (NCT03293784), involving 48 advanced melanoma patients treated with ICI or ICI in combination with anti-TNF (paired pre- and post-treatment samples). This evidence concerns the gene TNF and melanoma.